Clinical Decision Support System Market Size is Expected to Reach at USD 3,139 Million by 2030, Registering a CAGR of 9.8%, Owing to Increasing Adoption of Electronic Health Records
The Global Clinical Decision Support System Market Size is predicted to reach USD 3,139 Million by 2030 from USD 1,368 Million in 2021, at a CAGR of 9.8% between 2022 and 2030, as per the Acumen Research and Consulting
The growing need for remote patient monitoring services has encouraged market players to invest in advanced healthcare information systems, thus driving the growth of the clinical decision support systems (CDSS) market. Also, increasing support from government organizations is supporting the clinical decision support system market growth. Increasing popularity and preference for CDSS in healthcare facilities is the key trend witnessed in the global CDSS market currently. Despite these factors, data security issues and privacy concerns, since the patient’s personal information is stored in healthcare information systems, are the major factors restricting the growth of this market. High capital expenditure, regular maintenance, and lack of healthcare infrastructure in developing economies are other factors limiting the growth of the CDSS market size to some extent.
Clinical Decision Support System Market Statistics
- Global clinical decision support system market value was worth USD 1,368 Million in 2021, with a 9.8% CAGR from 2022 to 2030
- North America clinical decision support system market share occupied around 44.9% in 2021
- By mode of delivery, the on premises category capture over 46.2% of total market share in 2021
- Cerner is a leading CDSS provider, providing a wide range of solutions to healthcare providers
- Increased use of mobile devices and telemedicine, propel the clinical decision support system market revenue
Request for a sample of this premium research report@ https://www.acumenresearchandconsulting.com/request-sample/357
Clinical Decision Support System Market Trends
The clinical decision support system is an application that helps healthcare providers to make effective clinical decisions. It is an adaptation of decision support systems that are commonly used in managing business processes. These systems help in the implementation of clinical guidelines at the point of care. CDSS uses patient information to offer recommendations to healthcare providers on the treatment to be provided to the patient and delivers enhanced clinical outcomes. The major applications of clinical decision support systems include drug dosing support, drug-drug interactions, drug allergy alerts, clinical guidelines, and clinical reminders.
Clinical Decision Support System Market Segmentation
Acumen Research and Consulting has segmented the global clinical decision support system market by component, solutions, model, application, mode of delivery, and healthcare entity capacity.
- Based on the component, the market is categorized into services, software, and hardware. According to the clinical decision support system market forecast, the services segment is estimated to grow significantly over the next several years.
- Based on the solutions, the industry is divided into standalone CDSS solutions, and integrated CDSS solutions. Among these, integrated CDSS systems are the most popular, accounting for the largest market share in 2021, and are predicted to grow at the fastest CAGR from 2022 to 2030.
- Based on the model, the market is classified into non-knowledge-based CDSS solutions, and knowledge-based CDSS solutions.
- Based on the application, the industry is bifurcate into drug allergy alerts, drug-drug interactions, drug dosing support, clinical reminders, clinical guidelines, and others. The drug allergy alert segment held the largest proportion of the global CDSS market in 2021 and is predicted to increase at a strong CAGR during the forecast period. CDSS solutions are critical in providing patients with information about drug allergies and supporting healthcare providers in treating illnesses more effectively.
- Based on the mode of delivery, the industry is divided into cloud-based, on-premises, and web-based.
- Based on the healthcare entity capacity, the market is separated into less than 100 beds, 100-199 beds, 200-299 beds, 300-399 beds, 400-499 beds, and more than 500 beds.
Clinical Decision Support System Market Regional Overview
Geographically, the global clinical decision support system market can be divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. According to a clinical decision support system industry analysis, North America led the global market in 2021, accounting for the biggest revenue share. The established healthcare infrastructure, rise in the senior population, higher healthcare spending, and growing prevalence of chronic illnesses are driving the expansion of CDSS systems in North America. According to the American Diabetes Association, around 25.8 million Americans suffered from diabetes in 2010, with the figure rising to 29.1 million in 2012. According to the World Health Organization, around 324,000 new cases of lung cancer were discovered in North America in 2012, with the figure estimated to rise to 541,000 by 2030. The increasing demand for pharmaceuticals for illness management has had a substantial impact on the expansion of the CDSS market in North America. Throughout the projected period, North America is predicted to continue its dominant position in the CDSS market. Asia-Pacific is predicted to be the fastest-growing market for CDSS solution deployment. The growing need for remote patient monitoring and longer life expectancy are expected to enhance expenditures in healthcare IT solutions in the Asia-Pacific region, driving the clinical decision support system market size.
Clinical Decision Support System Market Players
Some of the prominent clinical decision support system market companies are General Electric Company, Allscripts Healthcare Solutions Inc., Siemens AG, Epic Systems Corporation, IBM Corporation, Mckesson Corporation, Zynx Health Incorporated, Cerner Corporation, Relx Group Plc, and Meditech. Leading companies in this market use a variety of significant methods to maintain market rivalry, including expanding their partnerships, forming strategic alliances for technology development and sharing, and making acquisitions.
Click here to buy the Premium Market Research report https://www.acumenresearchandconsulting.com/buy-now/0/357
Receive our personalized services and customization by clicking here https://www.acumenresearchandconsulting.com/request-customization/357
Mr. Frank Wilson
Acumen Research and Consulting
USA: +13474743864
India: +918983225533